Clinical trial
SPECT/CT in Endocrine and Neuroendocrine Tumors
NCT00230139 · Rambam Health Care Campus, Other · Completed
Key facts
| NCT number | NCT00230139 |
|---|---|
| Title | SPECT/CT in Endocrine and Neuroendocrine Tumors |
| Official title | The Added Value of SPECT/CT in the Evaluation of Endocrine and Neuroendocrine Tumors |
| Lead sponsor | Rambam Health Care Campus, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Endocrine and Neuroendocrine Tumors |
| Intervention type | Device |
| Interventions | SPECT/CT |
| Enrollment | 200 |
| Start date | Jan 1, 2002 |
| Primary completion | Jan 1, 2004 |
| Completion | Jan 1, 2006 |
| First posted | Sep 30, 2005 |
| Last update posted | Oct 15, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: